Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

FUSN

Fusion Pharmaceuticals Inc

May 09 • 04:00PM ET

21.38

Dollar change -0.02
Percentage change -0.09	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IBB MNA FHLC GINN ONEQ MRGR AVUS BIB AVSC IBBQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.42	Insider Own	32.99%	Shs Outstand	79.70M	Perf Week	-0.51%
Market Cap	1.82B	Forward P/E	-	EPS next Y	-1.62	Insider Trans	0.00%	Shs Float	56.93M	Perf Month	0.09%
Income	-104.28M	PEG	-	EPS next Q	-0.35	Inst Own	49.46%	Short Float	8.54%	Perf Quarter	88.87%
Sales	2.04M	P/S	890.52	EPS this Y	0.80%	Inst Trans	-2.65%	Short Ratio	2.38	Perf Half Y	375.11%
Book/sh	2.85	P/B	7.50	EPS next Y	-12.62%	ROA	-35.33%	Short Interest	4.86M	Perf Year	413.94%
Cash/sh	2.48	P/C	8.61	EPS next 5Y	-	ROE	-47.11%	52W Range	2.31 - 21.58	Perf YTD	122.48%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-80.83%	ROI	-34.52%	52W High	-0.93%	Beta	-0.69
Dividend TTM	-	Quick Ratio	10.64	Sales past 5Y	8.60%	Gross Margin	-32.21%	52W Low	825.54%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	10.64	EPS Y/Y TTM	28.83%	Oper. Margin	-5403.77%	RSI (14)	75.19	Volatility	0.45% 0.53%
Employees	113	Debt/Eq	0.27	Sales Y/Y TTM	125.66%	Profit Margin	-5111.57%	Recom	3.00	Target Price	20.95
Option/Short	Yes / Yes	LT Debt/Eq	0.25	EPS Q/Q	11.03%	Payout	-	Rel Volume	0.13	Prev Close	21.40
Sales Surprise	-100.00%	EPS Surprise	-7.73%	Sales Q/Q	-100.00%	Earnings	May 07 BMO	Avg Volume	2.04M	Price	21.38
SMA20	0.06%	SMA50	17.00%	SMA200	141.23%	Trades		Volume	264,014	Change	-0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-27-23	Upgrade	Raymond James	Outperform → Strong Buy	$12 → $15
Sep-29-23	Initiated	Oppenheimer	Outperform	$13
Jun-23-23	Initiated	Raymond James	Outperform	$13
Dec-01-22	Resumed	B. Riley Securities	Buy	$10
Nov-30-22	Initiated	SVB Leerink	Outperform	$6
Sep-16-22	Initiated	Truist	Buy	$10
Jul-06-22	Initiated	William Blair	Outperform
Oct-19-21	Resumed	Morgan Stanley	Overweight	$19
Aug-26-21	Initiated	B. Riley Securities	Buy	$17
Jul-21-20	Initiated	Wedbush	Outperform	$25
Jul-21-20	Initiated	Jefferies	Buy	$25
Jul-21-20	Initiated	Cowen	Outperform

Show Previous Ratings

Today 04:14PM	Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer (PR Newswire)
May-07-24 01:54PM	FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
07:00AM	Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates (PR Newswire)
May-02-24 10:01AM	Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-26-24 09:23AM	Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect (Zacks)
04:34PM	Loading…
Apr-25-24 04:34PM	Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order (PR Newswire)
Apr-23-24 06:15PM	Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Apr-17-24 06:15PM	Fusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should Know (Zacks)
Apr-11-24 05:50PM	Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know (Zacks)
Apr-09-24 04:05PM	Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024 (PR Newswire)
Apr-03-24 08:48AM	Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio (Investopedia)
Mar-25-24 02:52PM	31 European Countries That Offer Citizenship by Descent (Insider Monkey)
Mar-20-24 09:53PM	FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023 (InvestorPlace)
05:51PM	15 Countries with the Highest Life Expectancy in Africa (Insider Monkey)
04:05PM	Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates (PR Newswire)
01:21PM	Loading…
01:21PM	Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca (Zacks)
Mar-19-24 04:28PM	These Stocks Moved the Most Today: Nvidia, AMD, Super Micro, Fusion Pharmaceuticals, Nordstrom, International Paper, Tesla, and More (Barrons.com) +99.06%
04:02PM	Fusion Rockets 99%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover (Investor's Business Daily)
02:34PM	Stocks to Watch Tuesday: Super Micro, Fusion Pharmaceuticals, Nvidia, Unilever (The Wall Street Journal)
01:24PM	AstraZeneca acquires Fusion Pharmaceuticals in $2B deal (Yahoo Finance Video)
12:42PM	These Stocks Are Moving the Most Today (Barrons.com)
12:40PM	These Stocks Are Moving the Most Today: Nvidia, AMD, Super Micro, Fusion Pharmaceuticals, Nordstrom, International Paper, Tesla, and More (Barrons.com)
11:15AM	AstraZenca is betting $2 billion on next-gen cancer treatments (Quartz)
11:13AM	Fusion Pharmaceuticals Stock Soars. Its Being Acquired by AstraZeneca in $2.4 Billion Deal. (Barrons.com)
10:46AM	Super Micro, XPeng, AstraZeneca: Trending tickers (Yahoo Finance Video)
10:39AM	Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal (The Wall Street Journal)
09:03AM	Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover (Investor's Business Daily)
08:59AM	AstraZeneca signs agreement to acquire Fusion Pharmaceuticals (Pharmaceutical Business Review)
07:56AM	Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today? (InvestorPlace)
07:38AM	Fusion Pharmaceuticals Is Being Acquired by AstraZeneca in $2.4 Billion Deal. The Stock Is Soaring. (Barrons.com)
04:01AM	Loading…
04:01AM	AstraZeneca buys into radiopharmaceuticals with $2.4B deal for Fusion Pharma (BioPharma Dive)
03:22AM	UPDATE 3-AstraZeneca bets on next-generation cancer therapy with $2 bln Fusion deal (Reuters)
03:10AM	AstraZeneca bets on next-generation cancer therapy with $2 billion Fusion deal (Reuters)
03:07AM	AstraZeneca to buy Fusion Pharma for $2 billion in cash (Reuters)
03:00AM	Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer (PR Newswire)
Mar-06-24 07:45AM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) -5.71%
Mar-05-24 04:43PM	Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting (PR Newswire)
Feb-26-24 10:50AM	Fusion (FUSN) to Report Q4 Earnings: Here's What to Expect (Zacks)
07:45AM	Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences (PR Newswire)
Feb-20-24 06:30AM	These Drug Companies Are Going Nuclear to Fight Cancer (The Wall Street Journal) +10.96%
Feb-19-24 01:31PM	7 Low-Cost Call Options With High-Profit Potential (InvestorPlace)
Feb-16-24 08:45AM	Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy (PR Newswire)
Feb-07-24 07:45AM	Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +5.91%
Feb-06-24 04:45PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +5.48%
Jan-25-24 09:55AM	Wall Street Analysts Believe Fusion Pharmaceuticals Inc. (FUSN) Could Rally 35.09%: Here's is How to Trade (Zacks) +6.28%
Jan-17-24 12:00PM	What Makes Fusion Pharmaceuticals Inc. (FUSN) a New Strong Buy Stock (Zacks)
Jan-16-24 12:00PM	What Makes Fusion Pharmaceuticals Inc. (FUSN) a Strong Momentum Stock: Buy Now? (Zacks) +6.55%
08:22AM	Is it a Good Idea to Buy Fusion Pharmaceuticals (FUSN) Stock Now? (Zacks)
Jan-10-24 08:34AM	How Fusion Pharmaceuticals (FUSN) Stock Stands Out in a Strong Industry (Zacks)
Jan-09-24 06:21PM	Does Fusion Pharmaceuticals Inc. (FUSN) Have the Potential to Rally 47.76% as Wall Street Analysts Expect? (Zacks)
Jan-04-24 04:05PM	Fusion Pharmaceuticals Announces Clinical Program and Manufacturing Updates (PR Newswire) +6.84%
Dec-28-23 01:11PM	Why Fusion Pharmaceuticals (FUSN) Stock Was Up 14% on Wednesday (Zacks) +6.28%
Dec-27-23 02:42PM	Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned (Benzinga) +13.93%
11:02AM	Gracell downgrade, Fusion upgrade: Wall Street's top analyst calls (The Fly)
Dec-13-23 09:55AM	Wall Street Analysts Predict a 149.52% Upside in Fusion Pharmaceuticals Inc. (FUSN): Here's What You Should Know (Zacks)
Dec-08-23 12:00PM	Here's Why Fusion Pharmaceuticals Inc. (FUSN) is a Great Momentum Stock to Buy (Zacks)
Nov-27-23 09:55AM	How Much Upside is Left in Fusion Pharmaceuticals Inc. (FUSN)? Wall Street Analysts Think 162% (Zacks) -6.00%
Nov-16-23 06:45AM	Fusion Pharmaceuticals Strengthens Actinium Supply with Onsite Isotope Production through Expanded BWXT Medical Collaboration (PR Newswire)
06:45AM	BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology (Business Wire)
Nov-08-23 04:15PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
08:15AM	Fusion Pharmaceuticals to Present at Upcoming Investor Conferences (PR Newswire)
Nov-07-23 08:28AM	Fusion Pharmaceuticals Inc (FUSN) Reports Q3 2023 Financial Results and Clinical Program Updates (GuruFocus.com)
08:25AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
Oct-16-23 07:50AM	Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors (PR Newswire)
Oct-12-23 07:45AM	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers (PR Newswire)
Sep-06-23 04:25PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) -7.61%
Sep-05-23 04:10PM	Fusion Pharmaceuticals to Present at Upcoming September Investor Conferences (PR Newswire)
Aug-14-23 07:55AM	10 Oversold Penny Stocks To Buy (Insider Monkey)
Aug-09-23 04:05PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Aug-08-23 08:15AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
Aug-05-23 03:30PM	10 Oversold Canadian Stocks To Buy (Insider Monkey)
Jul-06-23 04:05PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) -5.02%
Jun-29-23 10:08AM	One Fusion Pharmaceuticals Insider Raised Stake By 370% In Previous Year (Simply Wall St.)
Jun-26-23 08:05AM	Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R (PR Newswire)
Jun-16-23 08:05AM	Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit (PR Newswire)
Jun-07-23 07:35AM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
May-31-23 04:10PM	Fusion Pharmaceuticals to Present at the Jefferies Healthcare Conference (PR Newswire) +18.06%
10:58AM	These 2 Strong Buy Penny Stocks Could Surge 200% (or More), Says Wedbush (TipRanks)
May-12-23 06:09AM	Fusion Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.)
May-11-23 07:15AM	Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates (PR Newswire)
May-10-23 08:34AM	Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) has caught the attention of institutional investors who hold a sizeable 34% stake (Simply Wall St.) +7.45%
May-09-23 07:45AM	Fusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day (PR Newswire)
May-02-23 04:00PM	Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer (PR Newswire) -7.56%
Apr-20-23 04:15PM	Fusion Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference (PR Newswire) -8.92%
Apr-19-23 04:25PM	Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2059 and Leading Targeted Alpha Therapy Platform at AACR Annual Meeting (PR Newswire) -7.07%
Apr-13-23 09:47AM	Fusion (FUSN) to Begin Clinical Study on Targeted Alpha Therapy (Zacks)
Apr-12-23 04:05PM	Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Jointly Developed Novel Targeted Alpha Therapy (PR Newswire)
Apr-05-23 04:10PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Mar-20-23 04:05PM	Fusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1 (PR Newswire)
Mar-16-23 08:45AM	Fusion Pharmaceuticals Inc. (FUSN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates (PR Newswire)
Mar-08-23 04:35PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Mar-02-23 04:35PM	Fusion Pharmaceuticals to Present at the 43rd Annual Cowen Healthcare Conference (PR Newswire) +6.11%
Feb-14-23 07:59AM	Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical (Benzinga) +22.10%
Feb-13-23 04:05PM	Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-PSMA I&T, a Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer (PR Newswire) +5.23%
08:05AM	Fusion Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference (PR Newswire)
Feb-07-23 04:10PM	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jan-20-23 08:33AM	A Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) insider increased their holdings by 370% last year (Simply Wall St.) -5.32%

Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FUSN

Fusion Pharmaceuticals Inc

Upgrade your FINVIZ experience